Genentech
KADCYLA
Manufacturer:
Genentech
Name:
KADCYLA
HCPCS Code Descriptor:
Injection, ado-trastuzumab emtansine, 1 mg
Category:
J Code
HCPCS:
J9354
NDC(s):
50242-0087-01, 50242-0088-01
Primary Type:
Oncology
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
KADCYLA is an Oncology drug manufactured by Genentech and administered via the Intravenous route of administration. The J Code: J9354 is aligned to the drug KADCYLA.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/14
HCPCS Effective Date:
1/1/14
HCPCS Short Description:
Inj, ado-trastuzumab emt 1mg
Billing and Coding Guide:
https://www.genentech-access.com/content/dam/gene/accesssolutions/pdfs/coding/KADCYLA-Billing-Coding-for-Breast-Cancer.pdf
Patient Assistance:
https://www.gene.com/patients/patient-foundation